Attaining true transparency in drug trials calls for a better solution than excessive redaction. Learn the drawbacks and benefits of the different methods for anonymization in clinical trials. There is potential for strong industry leaders to emerge — so long as they align themselves with best practice guidelines.
As reimbursement approaches shift, healthcare organizations will need better information on their costs and how to set prices for patients. Results of a recent study indicate they have a long way to go.